Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US

• المؤلفون الرئيسيون: Stephen I. Pelton (مؤلف), Joaquin F. Mould-Quevedo (مؤلف), Van Hung Nguyen (مؤلف)
• التنسيق: كتاب
• منشور في: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

ABSTRACTBackground Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness against seasonal influenza by avoiding mismatch from egg adaption of vaccine viruses. This study evaluates the population-level cost-effectiveness and impacts on health outcomes of QIVc versus an egg-base...